Title
Category
Credits
Event date
Cost
ISO2025: Optimizing Communication to Improve Management of Fracture Risk
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session explores how effective, patient-centered communication can improve the management of fracture risk in individuals with osteoporosis. It covers strategies for addressing health literacy, navigating barriers, and using shared decision-making tools to build trust, personalize care, and enhance treatment adherence.
ISO2025: Bone Health in the Transgender and Gender Diverse Youth Population
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session examines the impact of gender-affirming medical care on bone health in transgender and gender diverse (TGD) youth. It reviews skeletal development during puberty, the effects of puberty blockers and hormone therapy on bone density, and emerging research on long-term outcomes and fracture risk.
ISO2025: Year In Review
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session offers a comprehensive overview of the most important updates in osteoporosis and metabolic bone disease from the past year. Topics include emerging diagnostic tools, new treatment strategies, biosimilar developments, fracture healing insights, and highlights from major research and clinical practice guidelines.
ISO2025: Beyond Basics: DXA and Osteoporosis Cases
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session uses real-world cases to explore advanced challenges in interpreting DXA scans and managing osteoporosis. Participants will learn to identify common technical and clinical pitfalls, understand when reanalysis or rescanning is needed, and apply best practices for accurate diagnosis and treatment decisions.
ISO2025: Clinical Conundrums
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
Case study review and comments by health professionals. 
ISO2025: Osteoporosis/Bone Health in Premenopausal Women
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session explores the unique diagnostic, evaluation, and treatment challenges of osteoporosis in premenopausal women. It covers the distinctions from postmenopausal osteoporosis, underlying causes including secondary and idiopathic forms, and evidence-based strategies for managing bone health during the reproductive years.
ISO2025: Obesity, Weight loss (including GLP-1 agonists), and Bone Health
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session explores the complex relationship between obesity, weight loss, and skeletal health, highlighting how excess weight and weight reduction can both influence fracture risk and bone density. It also examines the effects of bariatric surgery, GLP-1 receptor agonists, and lifestyle interventions on bone metabolism, offering strategies to prevent bone loss and optimize outcomes.
ISO2025: Integrating Exercise & Rehabilitation: Enhancing Patient Care
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session highlights the role of exercise and rehabilitation in managing osteoporosis, focusing on safe movement strategies to build strength, improve balance, and reduce fall and fracture risk. It emphasizes the importance of individualized exercise programs, interprofessional collaboration, and patient communication to support long-term bone health.
ISO2025: Treating the Oldest Old
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session addresses the unique challenges and opportunities in managing osteoporosis in the oldest old population. It emphasizes individualized care, fall prevention, and evidence-based use of antiresorptive and anabolic therapies to reduce fracture risk and improve quality of life in older adults.
ISO2025: Discontinuation of Denosumab Treatment
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
This session examines the clinical and biological consequences of discontinuing denosumab, including the risk of rebound bone loss and vertebral fractures. It reviews the mechanisms behind these effects, current evidence on transition strategies to bisphosphonates, and expert recommendations for safe management following treatment cessation.

Pages